ANI Pharmaceuticals Inc (ANIP) - Financial and Strategic SWOT Analysis Review

ANI Pharmaceuticals Inc (ANIP) - Financial and Strategic SWOT Analysis Review

- SWOT Analysis Review provides you an provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets pharmaceuticals. The company’s product portfolio encompasses generic and branded tablets indicated for ulcerative colitis; osteoarthritis; rheumatoid arthritis; primary hypercholesterolemia; severe hypertriglyceridemia; arrhythmia; obsessive-compulsive disorder; social anxiety disorder; ulcerative proctitis; ulcerative proctosigmoiditis; bipolar disorder; glaucoma; metastatic prostate cancer; diarrhea; and pain. It caters to markets including oncolytics; complex formulations, hormones and steroids; and controlled substances. ANI also undertakes contract manufacturing of coated and non-coated capsules; oral dosage forms; liquid solution; topical liquids; suspension forms; and tablets. The company sells its products to wholesalers, group purchasing organizations, mail order houses in the US, and pharmacy retail outlets. ANI is headquartered in Baudette, Minnesota, the US.

ANI Pharmaceuticals Inc Key Recent Developments

May 09,2019: ANI Pharmaceuticals reports first quarter 2019 results and reaffirms guidance
Apr 15,2019: ANI Pharmaceuticals expands injectable portfolio with distribution agreement for FDA approved injectable product
Feb 27,2019: Ani Pharmaceuticals announces record full year and fourth quarter 2018 results and provides 2019 guidance
Aug 07,2018: ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
Jun 05,2018: ANI Pharmaceuticals Appoints Three New Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
ANI Pharmaceuticals Inc - Key Facts
ANI Pharmaceuticals Inc - Key Employees
ANI Pharmaceuticals Inc - Key Employee Biographies
ANI Pharmaceuticals Inc - Major Products and Services
ANI Pharmaceuticals Inc - History
ANI Pharmaceuticals Inc - Company Statement
ANI Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ANI Pharmaceuticals Inc - Business Description
Product Category: Branded Pharmaceutical Products
Overview
Performance
Product Category: Contract Manufacturing Services
Overview
Performance
Product Category: Generic Pharmaceutical Products
Overview
Performance
Product Category: Royalty and Other Income
Performance
R&D Overview
ANI Pharmaceuticals Inc - Corporate Strategy
ANI Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
ANI Pharmaceuticals Inc - Strengths
ANI Pharmaceuticals Inc - Weaknesses
ANI Pharmaceuticals Inc - Opportunities
ANI Pharmaceuticals Inc - Threats
ANI Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ANI Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 09, 2019: ANI Pharmaceuticals reports first quarter 2019 results and reaffirms guidance
Apr 15, 2019: ANI Pharmaceuticals expands injectable portfolio with distribution agreement for FDA approved injectable product
Feb 27, 2019: Ani Pharmaceuticals announces record full year and fourth quarter 2018 results and provides 2019 guidance
Aug 07, 2018: ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
Jun 05, 2018: ANI Pharmaceuticals Appoints Three New Board of Directors
May 08, 2018: ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance
Feb 27, 2018: ANI Pharmaceuticals Reports Record Full Year Results, Reports Fourth Quarter 2017 Results, and Provides 2018 Guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ANI Pharmaceuticals Inc, Key Facts
ANI Pharmaceuticals Inc, Key Employees
ANI Pharmaceuticals Inc, Key Employee Biographies
ANI Pharmaceuticals Inc, Major Products and Services
ANI Pharmaceuticals Inc, History
ANI Pharmaceuticals Inc, Other Locations
ANI Pharmaceuticals Inc, Subsidiaries
ANI Pharmaceuticals Inc, Key Competitors
ANI Pharmaceuticals Inc, Ratios based on current share price
ANI Pharmaceuticals Inc, Annual Ratios
ANI Pharmaceuticals Inc, Annual Ratios (Cont...1)
ANI Pharmaceuticals Inc, Annual Ratios (Cont...2)
ANI Pharmaceuticals Inc, Interim Ratios
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ANI Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
ANI Pharmaceuticals Inc, Performance Chart (2014 - 2018)
ANI Pharmaceuticals Inc, Ratio Charts
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook